Bazbaz, S.; Zaidman, I.; Even-Or, E.; Stepensky, P.; Sakran, R.; Kurnik, D.; Aldouby-Bier, G.
Once-Daily Versus Four-Times-Daily Intravenous Busulfan with Therapeutic Drug Monitoring as Conditioning for Hematopoietic Cell Transplantation in Children. Pharmaceutics 2025, 17, 1081.
https://doi.org/10.3390/pharmaceutics17081081
AMA Style
Bazbaz S, Zaidman I, Even-Or E, Stepensky P, Sakran R, Kurnik D, Aldouby-Bier G.
Once-Daily Versus Four-Times-Daily Intravenous Busulfan with Therapeutic Drug Monitoring as Conditioning for Hematopoietic Cell Transplantation in Children. Pharmaceutics. 2025; 17(8):1081.
https://doi.org/10.3390/pharmaceutics17081081
Chicago/Turabian Style
Bazbaz, Safaa, Irina Zaidman, Ehud Even-Or, Polina Stepensky, Razan Sakran, Daniel Kurnik, and Gefen Aldouby-Bier.
2025. "Once-Daily Versus Four-Times-Daily Intravenous Busulfan with Therapeutic Drug Monitoring as Conditioning for Hematopoietic Cell Transplantation in Children" Pharmaceutics 17, no. 8: 1081.
https://doi.org/10.3390/pharmaceutics17081081
APA Style
Bazbaz, S., Zaidman, I., Even-Or, E., Stepensky, P., Sakran, R., Kurnik, D., & Aldouby-Bier, G.
(2025). Once-Daily Versus Four-Times-Daily Intravenous Busulfan with Therapeutic Drug Monitoring as Conditioning for Hematopoietic Cell Transplantation in Children. Pharmaceutics, 17(8), 1081.
https://doi.org/10.3390/pharmaceutics17081081
